Share

November 12, 2019; 93 (20) Resident & Fellow Section

Teaching NeuroImages: 18F-FDG-PET/SPM analysis in 3 different stages from a patient with LGI-1 autoimmune encephalitis

Wei Shan, Xiao Liu, Qun Wang
First published November 11, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008473
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
720

Share

Article Information

vol. 93 no. 20 e1917-e1918
DOI: 
https://doi.org/10.1212/WNL.0000000000008473
PubMed: 
31712381
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published November 11, 2019.
Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Wei Shan, MD, PhD,
    2. Xiao Liu, MS and
    3. Qun Wang, MD, PhD
  1. Wei Shan, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This work was supported by National Key R&D Program of China 2017YFC1307500, Beijing-Tianjin-Hebei Cooperative Basic Research Program H2018206435, Capital Healthy Development Research Funding 2016-1-2011, Beijing Postdoctoral Research Foundation (Wei Shan)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Xiao Liu, MS and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This work was supported by National Key R&D Program of China 2017YFC1307500, Beijing-Tianjin-Hebei Cooperative Basic Research Program H2018206435, Capital Healthy Development Research Funding 2016-1-2011, Beijing Postdoctoral Research Foundation (Wei Shan)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Qun Wang, MD, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. This work was supported by National Key R&D Program of China 2017YFC1307500, Beijing-Tianjin-Hebei Cooperative Basic Research Program H2018206435, Capital Healthy Development Research Funding 2016-1-2011, Beijing Postdoctoral Research Foundation (Wei Shan) Signature: ／Qun Wang／ Date: Jun, 12th, 2019

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (W.S., X.L., Q.W.), Beijing Tiantan Hospital, Capital Medical University; National Center for Clinical Medicine of Neurological Diseases (W.S., X.L., Q.W.), Beijing; and Beijing Institute for Brain Disorders (W.S., X.L., Q.W.), China.
  1. Correspondence
    Dr. Qun wangq{at}ccmu.edu.cn
View Full Text

Article usage

Article usage: November 2019 to April 2023

AbstractFullPdfSource
Nov 20197431183Highwire
Dec 201968644Highwire
Jan 202004919Highwire
Feb 2020051120Highwire
Mar 2020012023Highwire
Apr 202006828Highwire
May 202025715Highwire
Jun 20201595Highwire
Jul 20200484Highwire
Aug 202007413Highwire
Sep 20201386Highwire
Oct 202004811Highwire
Nov 202004512Highwire
Dec 202014111Highwire
Jan 20210205Highwire
Feb 20210299Highwire
Mar 20210298Highwire
Apr 20211226Highwire
May 20210154Highwire
Jun 20211313Highwire
Jul 202101910Highwire
Aug 20210255Highwire
Sep 20210246Highwire
Oct 20210228Highwire
Nov 20210238Highwire
Dec 202102511Highwire
Jan 20220281Highwire
Feb 20220197Highwire
Mar 20220217Highwire
Apr 20221219Highwire
May 20220229Highwire
Jun 2022067Highwire
Jul 20220914Highwire
Aug 202202612Highwire
Sep 202201511Highwire
Oct 202201110Highwire
Nov 202201212Highwire
Dec 20220911Highwire
Jan 20231106Highwire
Feb 20230102Highwire
Mar 202301412Highwire
Apr 202302313Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles